Paper7697307
Intracavitary therapy of neoplastic effusions with cytokines: comparison among interferon alpha, beta and interleukin-2.
Lissoni P and 6 others. Support Care Cancer, 1995. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Intracavitary therapy of neoplastic effusions with cytokines: comparison among interferon alpha, beta and interleukin-2. Papers, record 7697307. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7697307
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ascitic Fluid | Major topic |
| Cytokines | Major topic |
| Neoplasms | Major topic |
| Pericardial Effusion | Major topic |
| Pleural Effusion, Malignant | Major topic |
| Adult | |
| Aged | |
| Drainage | |
| Female | |
| Humans | |
| Injections, Intralesional | |
| Interferon-alpha | |
| Interferon-beta | |
| Interleukin-2 | |
| Male | |
| Middle Aged | |
| Treatment Outcome |
Source PubMed
References4
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1175409 | Intrapleural tetracycline for malignant pleural effusions. | Chest | 1975 | https://conductscience.org/library/papers/1175409 | PubMed |
| 2 | 2407894 | Cancer, cytokines, and cytotoxic cells: interleukin-2 in the immunotherapy of human neoplasms. | Klin Wochenschr | 1990 | https://conductscience.org/library/papers/2407894 | PubMed |
| 3 | 383031 | The treatment of recurrent malignant pleural effusion. | Ann Thorac Surg | 1979 | https://conductscience.org/library/papers/383031 | PubMed |
| 4 | 62609 | Intracavitary bleomycin in the management of malignant effusions. | Cancer | 1976 | https://conductscience.org/library/papers/62609 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32315458 | Interventions for the management of malignant pleural effusions: a network meta-analysis. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/32315458 | PubMed |
| 27155783 | Interventions for the management of malignant pleural effusions: a network meta-analysis. | Cochrane Database Syst Rev | 2016 | https://conductscience.org/library/papers/27155783 | PubMed |
| 21160603 | Neoplastic pericardial disease: Old and current strategies for diagnosis and management. | World J Cardiol | 2010 | https://conductscience.org/library/papers/21160603 | PubMed |
| 12728148 | BTS guidelines for the management of malignant pleural effusions. | Thorax | 2003 | https://conductscience.org/library/papers/12728148 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| IFNA8 | 3445 | PubTator's text mining | https://conductscience.org/library/genes/3445 | NCBI Gene |
| IFNB1 | 3456 | PubTator's text mining | https://conductscience.org/library/genes/3456 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7697307
GET https://conductscience.org/api/papers/v1/7697307/authors